Prostate Cancer Mortality Among Elderly Men After Discontinuing Organised Screening: Long-term Results from the European Randomized Study of Screening for Prostate Cancer Rotterdam

Relationship Between Baseline Prostate-specific Antigen on Cancer Detection and Prostate Cancer Death: Long-term Follow-up from the European Randomized Study of Screening for Prostate Cancer

(2023) Sebastiaan Remmers et al.   EUROPEAN UROLOGY

A Detailed Evaluation of the Effect of Prostate-specific Antigen–based Screening on Morbidity and Mortality of Prostate Cancer: 21-year Follow-up Results of the Rotterdam Section of the European Randomised Study of Screening for Prostate Cancer

(2023) Ivo I. de Vos et al.   EUROPEAN UROLOGY

Low-Value Prostate-Specific Antigen Screening in Older Males

(2023) Sandhya Kalavacherla et al.   JAMA Network Open

Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening

(2023) John T. Wei et al.   JOURNAL OF UROLOGY

A Nationwide Analysis of Risk of Prostate Cancer Diagnosis and Mortality following an Initial Negative Transrectal Ultrasound Biopsy with Long-Term Followup

(2022) Sandra Miriam Kawa et al.   JOURNAL OF UROLOGY

Risk of prostate cancer and death after benign transurethral resection of the prostate—A 20‐year population‐based analysis

(2022) Maria Hilscher et al.   CANCER

Discontinuing Cancer Screening for Older Adults: a Comparison of Clinician Decision-Making for Breast, Colorectal, and Prostate Cancer Screenings

(2021) Justine P. Enns et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

Prostate Cancer Incidence and Mortality Following a Negative Biopsy in a Population Undergoing PSA Screening

(2021) Dudith Pierre-Victor et al.   UROLOGY

Age-Adjusted Reference Values for Prostate Specific Antigen – A Systematic Review and Meta-Analysis

(2021) Bashar Matti et al.   Clinical Genitourinary Cancer

Age dependence of modern clinical risk groups for localized prostate cancer—A population‐based study

(2020) Minh‐Phuong Huynh‐Le et al.   CANCER

General practitioners’ approaches to prostate-specific antigen testing in the north-east of the Netherlands

(2020) Sanny Kappen et al.   BMC Family Practice

EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent

(2020) Nicolas Mottet et al.   EUROPEAN UROLOGY

A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer

(2019) Jonas Hugosson et al.   EUROPEAN UROLOGY

Personalized risks of overdiagnosis for screen-detected prostate cancer incorporating patient comorbidities: Estimation and communication

(2019) Roman Gulati et al.   JOURNAL OF UROLOGY

Prostate Magnetic Resonance Imaging, with or Without Magnetic Resonance Imaging-targeted Biopsy, and Systematic Biopsy for Detecting Prostate Cancer: A Cochrane Systematic Review and Meta-analysis

(2019) Frank-Jan H. Drost et al.   EUROPEAN UROLOGY

Screening for Prostate Cancer

(2018) et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Estimating the harms and benefits of prostate cancer screening as used in common practice versus recommended good practice: A microsimulation screening analysis

(2016) Sigrid V. Carlsson et al.   CANCER

Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015

(2016) Haidong Wang et al.   LANCET

Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen

(2014) Andrew J Vickers et al.   BMC Medicine

Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks

(2013) Paul Blanche et al.   STATISTICS IN MEDICINE

Impact of Age at Diagnosis on Prostate Cancer Treatment and Survival

(2010) Seth K. Bechis et al.   JOURNAL OF CLINICAL ONCOLOGY

Prostate Cancer in Men 70 Years Old or Older, Indolent or Aggressive: Clinicopathological Analysis and Outcomes

(2010) Stephen A. Brassell et al.   JOURNAL OF UROLOGY

Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer

(2009) E A M Heijnsdijk et al.   BRITISH JOURNAL OF CANCER